SUNWAY CITY, May 27 — Sunway Healthcare Group has become the first Malaysian private healthcare entity to collaborate with global pharmaceutical giant AstraZeneca, following the signing of a Memorandum of Understanding (MOU) at the Sunway Sanctuary. The MOU, signed by Dr. Khoo Chow Huat, Managing Director of Hospital & Healthcare Operations at Sunway Healthcare Group, and Vinod Narayanan, Country President of AstraZeneca Malaysia, aims to boost clinical trials, research, and service implementation to improve healthcare delivery.
The partnership will initially focus on early screening for lung cancer and integrating the Kidney Failure Risk Equation into lab reports for better management of chronic kidney disease. The collaboration will also explore clinical trials, real-world evidence generation, molecular diagnostics, and the use of AI in digital pathology and healthcare solutions. Vinod Narayanan highlighted that this initiative underscores AstraZeneca’s commitment to advancing clinical research and accelerating the development of innovative medicines.
